Management of muscle-invasive bladder cancer (MIBC) has changed little in the last twenty years. The gold standard treatment is still cystectomy, but it has a significant negative impact on quality of life. Bladder-preservation strategies can be used in some cases but patient selection for this approach remains unclear. New chemotherapy and biologic agents in combination with surgery or radiotherapy could improve results and these possibilities are currently under investigation.
|Journal||Clinical and Translational Oncology|
|Publication status||Published - 1 Dec 2011|
- Infi ltrating bladder cancer
- Transurethral resection of the bladder